학술논문
The role of angiogenesis inhibitors associated with tyrosine kinase inhibitors in the first-line treatment for EGFR-mutated advanced lung cancer
Document Type
Review Article
Author
Source
In Critical Reviews in Oncology / Hematology April 2024 196
Subject
Language
ISSN
1040-8428